TheEdgeResearch
Home / Stocks / AMHD

HLK Biotech Holding Group, Inc. (AMHD)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$925
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.98
52-Wk Range
0.0002-0.0002
CEO
Anna Petinova
Country
US
Currency
USD

HLK Biotech Holding Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Norfolk, VA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $925. Its beta of 0.98 implies it has historically moved less than the broad market.

Company profile
Exchange
Other OTC
Employees
5
IPO date
1999-02-11
Headquarters
Norfolk, VA, US
About HLK Biotech Holding Group, Inc.

HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate assets. The firm was formerly recognized as Amelot Holdings, Inc., but it officially rebranded to HLK Biotech Holding Group, Inc. in February 2018. The company's principal office is located in Norfolk, Virginia.

Comparable companies

HLK Biotech Holding Group, Inc. is most often compared with the following Healthcare names:

CALACNNXFDMKPQEFTRIGNTLITHMILCMMTCPJETUTRS
More research on AMHD
AMHD technical analysis AMHD TheEdge Score Compare against peers
Open full interactive analysis & DCF →